2024 annual financial data
CytomX Therapeutics 2024 Operating margin
CytomX Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was 18.1%.
Operating income was 24,995,000 USD and net income was 31,869,000 USD.
Operating cash flow was -86,231,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 138,103,000 USD
- Operating income
- 24,995,000 USD
- Net income
- 31,869,000 USD
- Operating cash flow
- -86,231,000 USD